Getting to Know the Abecma (ide-cel) CAR T Therapy image

Getting to Know the Abecma (ide-cel) CAR T Therapy

May 18, 2021
12:00PM - 01:00PM EDT
Online Event
Overview

Everyone has been hearing about the newly FDA-approved Abecma (ide-cel) CAR T therapy, but what is this treatment? Who qualifies for it? And how can you sign up? Hear from multiple myeloma specialist Dr. Nina Shah as she shares the practical side of the CAR T and answers your questions. 

Agenda
12:00 PM
Introductions
Audrey Burton-Bethke
Audrey welcomes everybody, shares the agenda for the event and introduces our featured speaker, Dr. Nina Shah. 
12:05 PM
Presentation
Dr. Nina Shah
Dr. Nina Shah shares the practical side of the Abecma (ide-cel) CAR T Therapy, who qualifies for it, and how to sign up.
12:35 PM
Q&A
Audience
Dr. Shah answers the audience's questions about her presentation and CAR T.
Speakers & Moderators
Healthtree contact Jennifer Ahlstrom

Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of the HealthTree Foundation.
Healthtree contact Audrey Burton-Bethke

Audrey Burton-Bethke

Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.
Healthtree contact Nina Shah, MD

Nina Shah, MD

Dr. Nina Shah is a specialist in blood diseases who focuses on treating multiple myeloma, a type of cancer affecting certain cells in the bone marrow. Her areas of professional interest include the intersection of immunology and oncology as well as helping patients fight multiple myeloma by boosting their immune systems. Shah earned a bachelor's degree in cognitive neuroscience at Harvard University, followed by a medical degree from New York University School of Medicine. She completed a residency in internal medicine at Columbia University and a fellowship in hematology-oncology at the University of Texas MD Anderson Cancer Center. Shah belongs to the American Society of Clinical Oncology, American Society of Hematology and American Society for Transplantation and Cellular Therapy. She speaks Bengali and Spanish.